Patent · US Active

Spiroindolinone derivatives

US7834179B2 · kind B2 · utility

6Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2008
Grant dateNov 16, 2010
Priority date—
Expiry dateFeb 27, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

There are provided spiroindolinone derivatives of the formulaand pharmaceutically acceptable salts and esters thereof wherein R1, R2, R3, R4 and R are as herein described. The compounds exhibit anticancer activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.